Log In or Register to Join The Conversation!

This topic is empty.

  • Author
    Posts
    • #24531
      Kevin Schaefer
      Keymaster

      On Friday, August 7th, the FDA announced the approval of Evrysdi (Risdiplam), the first oral treatment for all types of SMA. BioNews frequently launches surveys to gauge the thoughts of community members. Your perspective may help better inform and improve how the medical industry treats people with SMA. Should this survey yield valuable insights, the results will be shared with the SMA community. This survey will take 2-3 minutes to complete. Your insights are appreciated.

      Click here to take the survey

      • This topic was modified 3 months, 1 week ago by Kevin Schaefer.
      • This topic was modified 3 months, 1 week ago by Ryan Golley.
      • This topic was modified 3 months, 1 week ago by Ryan Golley.
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2020 All rights reserved.